Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory Mayzent: New Drug for Treatment of Secondary Progressive Multiple Sclerosis April 1, 2021September 8, 2022 Siponimod released by Novartis is an improved version of Gilenya.
